Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corgenix Changes Date and Time of Its Hosted Conference Call to Discuss Second Quarter Fiscal 2008 Results.


DENVER -- Corgenix Medical Corporation (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
: CONX), a worldwide developer and marketer of diagnostic test kits, has changed the date and time which it will host a conference call to Tuesday, February 12, 2008 at 4:00 PM EST EST electroshock therapy.

EST
abbr.
electroshock therapy
 in which it will discuss the Company's financial and operating performance for its second quarter 2008 and the status of the Company's product development and marketing activities.

Corgenix invites all those interested in hearing management's discussion of the quarter results to join the call by dialing:

U.S. attendees: 800-895-0198

International attendees: +1-785-424-1053

Conference code is: CORGENIX

A question-and-answer session will follow the presentation by Corgenix management.

A replay will be available for 30 days following the call by dialing 800-727-6189 for U.S. participants and +1-402-220-2671 for international participants.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized spe·cial·ize  
v. spe·cial·ized, spe·cial·iz·ing, spe·cial·iz·es

v.intr.
1. To pursue a special activity, occupation, or field of study.

2.
 diagnostic kits for immunology immunology, branch of medicine that studies the response of organisms to foreign substances, e.g., viruses, bacteria, and bacterial toxins (see immunity). Immunologists study the tissues and organs of the immune system (bone marrow, spleen, tonsils, thymus, lymphatic  disorders, vascular diseases vascular diseases,
n.pl diseases of the peripheral circulatory system.
 and bone and joint disorders. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 process. More information is available at www.corgenix.com.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 6, 2008
Words:199
Previous Article:Houston Technology Center Names New Chairman of Advisory Board.
Next Article:Cooper Industries to Hold Annual Investor Outlook Meeting.
Topics:



Related Articles
Corgenix to Host Conference Call to Discuss Second Quarter Fiscal 2006 Results.
Corgenix to Host Conference Call to Discuss Fiscal Fourth Quarter and 2006 Year-End Results.
Corgenix to Release Fiscal 2007 First Quarter Results and Host Conference Call on November 14, 2006.
Corgenix to Release Fiscal 2007 Second Quarter Results and Host Conference Call on February 14, 2007.
Corgenix Reports Second Quarter Fiscal 2007 Financial Results.
Corgenix Reports 23% Increase in Revenue for Third Quarter Fiscal 2007.
Corgenix Reports Record Sales for Fiscal 2007.
Corgenix Reports Record Revenue and Improved Results from Operations for First Quarter of Fiscal 2008.
Corgenix to Host Conference Call to Discuss Second Quarter Fiscal 2008 Results.
Corgenix Reports Second Quarter Fiscal 2008 Financial Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles